These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11074481)

  • 1. Protective titres of measles neutralising antibody.
    Lee MS; Nokes DJ; Hsu HM; Lu CF
    J Med Virol; 2000 Dec; 62(4):511-7. PubMed ID: 11074481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997.
    Lee MS; Chien LJ; Yueh YY; Lu CF
    Vaccine; 2001 Sep; 19(32):4644-51. PubMed ID: 11535312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.
    Rabenau HF; Marianov B; Wicker S; Allwinn R
    Med Microbiol Immunol; 2007 Sep; 196(3):151-5. PubMed ID: 17308917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
    Nates SV; Rey GY; Giordano MO; Depetris AR; Boshell J
    Viral Immunol; 1995; 8(1):47-52. PubMed ID: 8546804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
    LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
    Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to measles revaccination among Bolivian school-aged children.
    Bartoloni A; Cutts FT; Guglielmetti P; Brown D; Bianchi Bandinelli ML; Hurtado H; Roselli M
    Trans R Soc Trop Med Hyg; 1997; 91(6):716-8. PubMed ID: 9509188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.
    Lee MS; Cohen B; Hand J; Nokes DJ
    J Virol Methods; 1999 Mar; 78(1-2):209-17. PubMed ID: 10204711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
    Whittle HC; Campbell H; Rahman S; Armstrong JR
    Lancet; 1990 Oct; 336(8722):1046-8. PubMed ID: 1977029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
    Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
    Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay.
    van den Hof S; van Gageldonk-Lafeber AB; van Binnendijk RS; van Gageldonk PG; Berbers GA
    Vaccine; 2003 Oct; 21(27-30):4210-4. PubMed ID: 14505900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccinees.
    Bouche F; Ammerlaan W; Fournier P; Schneider F; Muller CP
    J Virol Methods; 1998 Sep; 74(1):77-87. PubMed ID: 9763131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced seroconversion to measles in infants given vitamin A with measles vaccination.
    Semba RD; Munasir Z; Beeler J; Akib A; Muhilal ; Audet S; Sommer A
    Lancet; 1995 May; 345(8961):1330-2. PubMed ID: 7752754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population.
    Mossong J; O'Callaghan CJ; Ratnam S
    Vaccine; 2000 Oct; 19(4-5):523-9. PubMed ID: 11027817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.